p773–782 

General Information


DCTPep ID  DCTPep00108

Peptide Name   p773–782 

Sequence  VMAGVGSPYV

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

ACP Tumor active peptide Immune system stimulating peptides



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
N202.A2 Spontaneous tumor in A2×neu mice Animals immunized three times with DC pulsed with p369–377 or p773–782 peptide showed ~25–30% tumor growth inhibition, while two immunizations induced ~12–15% tumor growth inhibition and one injection Not available Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  The low-avidity T cell repertoire for a self tumor antigen is functional, can be activated and expanded with the help of costimulation



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C44H70N10O13S1

Absent amino acids  CDEFHIKLNQRTW

Theoretical pI  5.49

Acidic residues  0

Basic residues  0

Polar residues  4

Molecular weight (Average)  979.16

Molecular weight (Monoisotopic)  978.48

Common amino acids  V

Net charge  0

Instability index (II)  56.79

Aliphatic index  97.00

Grand average of hydropathicity (GRAVY)  1.180

Half Life 
  100 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 1490
  Abs 0.1% (=1 g/l) 1.522

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 14991605

Title  The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity

Doi 10.1002/eji.200324427

Year  2004

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.